According to Insmed's latest financial reports the company's current earnings are HK$0.36 Billion. a decrease over its 2023 earnings that were of -HK$5.21 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -HK$6.44 Billion | 23.71% |
2023 | -HK$5.21 Billion | 45.77% |
2022 | -HK$3.57 Billion | 15.83% |
2021 | -HK$3.09 Billion | 50.19% |
2020 | -HK$2.06 Billion | 16.4% |
2019 | -HK$1.77 Billion | -23.9% |
2018 | -HK$2.32 Billion | 59.35% |
2017 | -HK$1.46 Billion | 8.52% |
2016 | -HK$1.34 Billion | 47.25% |
2015 | -HK$0.91 Billion | 34.53% |
2014 | -HK$0.68 Billion | 58.83% |
2013 | -HK$0.43 Billion | 35.14% |
2012 | -HK$0.32 Billion | -31.92% |
2011 | -HK$0.47 Billion | 854.92% |
2010 | -HK$48.46 Million | -105.22% |
2009 | HK$0.92 B | -905.06% |
2008 | -HK$0.12 Billion | -27.31% |
2007 | -HK$0.16 Billion | -62.41% |
2006 | -HK$0.43 Billion | 98.19% |
2005 | -HK$0.22 Billion | 0.03% |
2004 | -HK$0.22 Billion | 159.07% |
2003 | -HK$82.12 Million | -69.31% |
2002 | -HK$0.27 Billion | |
2000 | -HK$0.25 Billion |